Literature DB >> 3098232

Arachidonic acid turnover in response to lipopolysaccharide and opsonized zymosan in human monocyte-derived macrophages.

C C Leslie, D M Detty.   

Abstract

Macrophages are an important source of the lipid mediators, arachidonic acid metabolites and platelet-activating factor (PAF), produced during inflammation. Studies were undertaken to identify the phospholipid substrates that can serve as a source of arachidonic acid in human monocyte-derived macrophages exposed to the inflammatory stimuli bacterial lipopolysaccharide (LPS) and opsonized zymosan (OpZ). Since PAF is derived from 1-alkyl-2-acyl-glycerophosphocholine, it was of interest to determine if this phospholipid precursor could also serve as a source of arachidonic acid. The day-5 macrophages incorporated 38% of the available [3H]arachidonic acid into lipid by 4 h, 54% of which was in phospholipid [phosphatidylcholine (PC) greater than phosphatidylethanolamine (PE) greater than phosphatidylinositol (PI)]. The proportion of label incorporated into ether-linked PC and PE increased with time. After prelabelling with [3H]arachidonic acid, the effect of stimuli on the redistribution of label within phospholipids was followed. Without stimulus there was a loss of label from PC, PI and phosphatidic acid by 3 h, but an increase of label in PE. The [3H]arachidonic acid that was lost from PC in the absence of stimulus was derived solely from the 1-acyl-linked species of PC, whereas an increase in label occurred in the 1-alkyl-linked species of PC. By contrast, LPS stimulation resulted in a preferential, dose-dependent loss of label from PC and PI, which was maximal between 1 and 3 h after adding the LPS. In addition, LPS induced a 35% decrease in the molar quantity of PI in the macrophages but had no effect on the quantity of PC, PE or phosphatidylserine. Stimulation with OpZ also resulted in a loss of label, mainly from PC and PI. Of the total label lost from PC in response to LPS or OpZ, approx. 50% was derived from the 1-alkyl-linked species. The results suggest that phospholipase C- and phospholipase A2-mediated mechanisms for arachidonic acid release are activated in human macrophages exposed to the inflammatory stimuli LPS and OpZ. In addition, 1-alkyl-linked PC can serve as a source of arachidonic acid and as a precursor for PAF production in the stimulated macrophages.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3098232      PMCID: PMC1146813          DOI: 10.1042/bj2360251

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

Review 1.  Inositol phospholipids and cell surface receptor function.

Authors:  R H Michell
Journal:  Biochim Biophys Acta       Date:  1975-03-25

2.  Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide.

Authors:  C Haslett; L A Guthrie; M M Kopaniak; R B Johnston; P M Henson
Journal:  Am J Pathol       Date:  1985-04       Impact factor: 4.307

3.  The separation, long-term cultivation, and maturation of the human monocyte.

Authors:  W D Johnson; B Mei; Z A Cohn
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

4.  Lipids of alveolar macrophages, polymorphonuclear leukocytes, and their phagocytic vesicles.

Authors:  R J Mason; T P Stossel; M Vaughan
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

5.  1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes.

Authors:  F H Chilton; J M Ellis; S C Olson; R L Wykle
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

6.  Release of arachidonic acid from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine, a precursor of platelet-activating factor, in rat alveolar macrophages.

Authors:  D H Albert; F Snyder
Journal:  Biochim Biophys Acta       Date:  1984-10-24

7.  Differences in the ability of human peripheral blood monocytes and in vitro monocyte-derived macrophages to produce superoxide anion: studies with cells from normals and patients with chronic granulomatous disease.

Authors:  R A Musson; L C McPhail; H Shafran; R B Johnston
Journal:  J Reticuloendothel Soc       Date:  1982-03

8.  Lipid peroxidation by human blood phagocytes.

Authors:  T P Stossel; R J Mason; A L Smith
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

9.  CoA-independent transfer of arachidonic acid from 1,2-diacyl-sn-glycero-3-phosphocholine to 1-O-alkyl-sn-glycero-3-phosphocholine (lyso platelet-activating factor) by macrophage microsomes.

Authors:  T Sugiura; K Waku
Journal:  Biochem Biophys Res Commun       Date:  1985-02-28       Impact factor: 3.575

10.  Regulation of arachidonic acid metabolites in macrophages.

Authors:  W A Scott; J M Zrike; A L Hamill; J Kempe; Z A Cohn
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

View more
  7 in total

1.  Activation of human peripheral blood monocytes by lipoproteins.

Authors:  J L Kelley; M M Rozek; C A Suenram; C J Schwartz
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

2.  N-6 and n-3 polyunsaturated fatty acids stimulate translocation of protein kinase Calpha, -betaI, -betaII and -epsilon and enhance agonist-induced NADPH oxidase in macrophages.

Authors:  Z H Huang; C S Hii; D A Rathjen; A Poulos; A W Murray; A Ferrante
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

3.  Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes.

Authors:  P E Poubelle; D Gingras; C Demers; C Dubois; D Harbour; J Grassi; M Rola-Pleszczynski
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

4.  Potential phospholipid source(s) of arachidonate used for the synthesis of leukotrienes by the human neutrophil.

Authors:  F H Chilton
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

5.  Dual Ca2+ requirement for optimal lipid peroxidation of low density lipoprotein by activated human monocytes.

Authors:  Q Li; A Tallant; M K Cathcart
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  Suppression of the development of tumoricidal function in gamma interferon-treated human peripheral blood monocytes by lipopolysaccharide: the role of cyclooxygenase metabolites.

Authors:  E Chu; L C Casey; J E Harris; D P Braun
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

Review 7.  Recent advances in our understanding of the biochemical interactions between platelet-activating factor and arachidonic acid.

Authors:  F H Chilton; M Cluzel; M Triggiani
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.